scholarly journals 010: Prediction of long-term survival in patients receiving optimal secondary prevention therapy after acute myocardial infarction: the FAST-MI registry

2013 ◽  
Vol 5 (1) ◽  
pp. 4
Author(s):  
Etienne Puymirat ◽  
Nadia Aissaoui ◽  
Gilles Lemesle ◽  
Luc Lorgis ◽  
Elodie Drouet ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Secondary Prevention ◽  
Term Survival ◽  
Long Term Survival ◽  
Prevention Therapy

scholarly journals Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure

Heart ◽  
2021 ◽  
Vol 107 (5) ◽  
pp. 389-395
Author(s):  
Jianhua Wu ◽  
Alistair S Hall ◽  
Chris P Gale
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Acute Myocardial Infarction ◽  
Life Expectancy ◽  
Survival Benefit ◽  
Ace Inhibition ◽  
Survival Times ◽  
Term Survival ◽  
Long Term Survival

AimsACE inhibition reduces mortality and morbidity in patients with heart failure after acute myocardial infarction (AMI). However, there are limited randomised data about the long-term survival benefits of ACE inhibition in this population.MethodsIn 1993, the Acute Infarction Ramipril Efficacy (AIRE) study randomly allocated patients with AMI and clinical heart failure to ramipril or placebo. The duration of masked trial therapy in the UK cohort (603 patients, mean age=64.7 years, 455 male patients) was 12.4 and 13.4 months for ramipril (n=302) and placebo (n=301), respectively. We estimated life expectancy and extensions of life (difference in median survival times) according to duration of follow-up (range 0–29.6 years).ResultsBy 9 April 2019, death from all causes occurred in 266 (88.4%) patients in placebo arm and 275 (91.1%) patients in ramipril arm. The extension of life between ramipril and placebo groups was 14.5 months (95% CI 13.2 to 15.8). Ramipril increased life expectancy more for patients with than without diabetes (life expectancy difference 32.1 vs 5.0 months), previous AMI (20.1 vs 4.9 months), previous heart failure (19.5 vs 4.9 months), hypertension (16.6 vs 8.3 months), angina (16.2 vs 5.0 months) and age >65 years (11.3 vs 5.7 months). Given potential treatment switching, the true absolute treatment effect could be underestimated by 28%.ConclusionFor patients with clinically defined heart failure following AMI, ramipril results in a sustained survival benefit, and is associated with an extension of life of up to 14.5 months for, on average, 13 months treatment duration.

Long Term Survival Rate and Prognostic Factors of Acute Myocardial Infarction

1999 ◽  
Vol 29 (1) ◽  
pp. 14 ◽  
Author(s):  
Seok-Yeon Kim ◽  
Joo-Yong Han ◽  
Yong-Jin Kim ◽  
Ji-Dong Sung ◽  
In-Ho Chae ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Prognostic Factors ◽  
Survival Rate ◽  
Term Survival ◽  
Long Term Survival

Frequency of Sexual Activity and Long-term Survival after Acute Myocardial Infarction

2020 ◽  
Vol 133 (1) ◽  
pp. 100-107 ◽  
Author(s):  
Shlomit Brandis Kepler ◽  
Tal Hasin ◽  
Yael Benyamini ◽  
Uri Goldbourt ◽  
Yariv Gerber
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Sexual Activity ◽  
Term Survival ◽  
Long Term Survival

Improvement in Long-Term Survival among Patients Hospitalized with Acute Myocardial Infarction, 1970 to 1980

1987 ◽  
Vol 316 (22) ◽  
pp. 1353-1359 ◽  
Author(s):  
Orlando Gomez-Marin ◽  
Aaron R. Folsom ◽  
Thomas E. Kottke ◽  
Shu-Chen H. Wu ◽  
David R. Jacobs ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Term Survival ◽  
Long Term Survival

Impact of Diabetes on Long-Term Survival After Acute Myocardial Infarction: Comparability of risk with prior myocardial infarction

Diabetes Care ◽  
2001 ◽  
Vol 24 (8) ◽  
pp. 1422-1427 ◽  
Author(s):  
K. J. Mukamal ◽  
R. W. Nesto ◽  
M. C. Cohen ◽  
J. E. Muller ◽  
M. Maclure ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Term Survival ◽  
Long Term Survival ◽  
Prior Myocardial Infarction

scholarly journals Abciximab-Supported Infarct Artery Stent Implantation for Acute Myocardial Infarction and Long-Term Survival

Circulation ◽  
2004 ◽  
Vol 109 (14) ◽  
pp. 1704-1706 ◽  
Author(s):  
David Antoniucci ◽  
Angela Migliorini ◽  
Guido Parodi ◽  
Renato Valenti ◽  
Alfredo Rodriguez ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Stent Implantation ◽  
Term Survival ◽  
Long Term Survival
Sign in / Sign up

Export Citation Format

Share Document